Protection against haloperidol by catatoxic steroids.
D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D004336:Drug Antagonism; D004357:Drug Synergism; D005032:Ethylestrenol / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000037:antagonists & inhibitors*; D007659:Ketones / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D010074:Oxandrolone / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011278:Pregnanes / Q000494:pharmacology*; D011284:Pregnenolone / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology; D014221:Triamcinolone / Q000494:pharmacology
D007659:Ketones; D009570:Nitriles; D011278:Pregnanes; D014221:Triamcinolone; D013148:Spironolactone; D011374:Progesterone; D011284:Pregnenolone; D010074:Oxandrolone; D011239:Prednisolone; D005032:Ethylestrenol; D006220:Haloperidol; D013974:Thyroxine; D010634:Phenobarbital